Autotelic Bio Successfully Raised KRW 15.5 Billlion in Series B Investment
2022-03-28
ATB-101, a Fixed Dose Combination for Hypertension and Diabetes Got IND Approval for Phase 1 Clinical Trial
2021-03-02
Autotelic Bio Signed Agreement with Clinigen for Clinical Trials of Anti-cancer New Drug
2021-01-14
Autotelic Bio Raised Strategic Investment
2020-09-06
Autotelic Bio Raised Series A Investment
2020-01-07
Autotelic Bio-ST Pharm Signed Agreement for Manufacturing and Supplying Trabederson
2019-05-28
